人工智能减少或消除脑与心脏MRI钆对比剂需求的文献综述
本文综述了近期利用人工智能合成虚拟对比增强脑与心脏MRI图像、以减少或替代钆对比剂注射的研究。若可行,可降低费用、缩短采集时间并减少环境影响,但需更多研究使AI方案可靠稳健以整合入临床框架。
要点
- AI可合成虚拟对比增强图像,有望在减少或不注射钆对比剂时提供类似诊断信息
- 潜在获益包括降低成本、缩短采集时间和减少环境负担
- 目前证据尚不足以将AI方案常规整合入临床,需更多研究验证其可靠性与稳健性
英文原文(摘要)· 点击展开
Brain and cardiac MRIs are fundamental noninvasive imaging tools, which can provide important clinical information and can be performed without or with gadolinium-based contrast agents (GBCAs), depending on the clinical indication. It is currently a topic of debate whether it would be feasible to extract information such as standard gadolinium-enhanced MRI while injecting either less or no GBCAs. Artificial intelligence (AI) is a great source of innovation in medical imaging and has been explored as a method to synthesize virtual contrast MR images, potentially yielding similar diagnostic performance without the need to administer GBCAs. If possible, there would be significant benefits, including reduction of costs, acquisition time, and environmental impact with respect to conventional contrast-enhanced MRI examinations. Given its promise, we believe additional research is needed to increase the evidence to make these AI solutions feasible, reliable, and robust enough to be integrated into the clinical framework. Here, we review recent AI studies aimed at reducing or replacing gadolinium in brain and cardiac imaging while maintaining diagnostic image quality.
引用
- Mallio, Radbruch, Deike-Hofmann, et al. Artificial Intelligence to Reduce or Eliminate the Need for Gadolinium-Based Contrast Agents in Brain and Cardiac MRI: A Literature Review. Invest Radiol. 2023. PMID: 37126454. doi:10.1097/RLI.0000000000000983
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。